Načítá se...
The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases
In vivo exploration of neurodegenerative diseases by positron emission tomography (PET) imaging has matured over the last 20 years, using dedicated radiopharmaceuticals targeting cellular metabolism, neurotransmission, neuroinflammation, or abnormal protein aggregates (beta-amyloid and intracellular...
Uloženo v:
| Vydáno v: | Contrast Media Mol Imaging |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5985069/ https://ncbi.nlm.nih.gov/pubmed/29887768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7043578 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|